Skip to content

HECK PHARMA: what changed

BE 0779.610.477NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€176,188
2024 · €123,117+€53,071
Equity
€168,197
2024 · €132,009+€36,188
Cash
€318,656
2024 · €229,599+€89,057
Balance sheet total
€522,168
2024 · €441,119+€81,050

Largest movements

2024 to 2025
Assets
  • Cash +€89,057

    up €89,057 (+38.8%), from €229,599 to €318,656

    mainly Net result for the year (+€176,188) and Other debts (+€38,749)

  • Receivables within one year -€14,126

    down €14,126 (-12.4%), from €113,544 to €99,418

    of which Trade receivables: -€13,505

  • Stocks and contracts +€10,408

    up €10,408 (+12.6%), from €82,823 to €93,231

Equity and liabilities
  • Other debts +€38,749

    up €38,749 (+38.6%), from €100,307 to €139,056

  • Profit (loss) carried forward +€36,188

    up €36,188 (+32.3%), from €112,009 to €148,197

  • Tax, wage and social debts +€21,192

    up €21,192 (+54.9%), from €38,601 to €59,793

    of which Taxes: +€22,671

  • Trade debts -€15,080

    down €15,080 (-8.9%), from €170,202 to €155,122

Income statement
  • Gross operating margin +€81,557

    up €81,557 (+22.0%), from €370,354 to €451,911

  • Taxes +€20,521

    up €20,521 (+46.2%), from €44,379 to €64,900

  • Staff costs +€10,036

    up €10,036 (+5.3%), from €190,919 to €200,955

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €123,117
Gross operating margin +€81,557
Staff costs -€10,036
Depreciation -€379
Other operating charges -€405
Financial income +€2,116
Financial charges +€738
Taxes -€20,521
Result 2025 €176,188
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€229,057
Investment €0
Financing -€140,000
Cash 2024 €229,599
Net result for the year +€176,188
Depreciation +€4,983
Stocks and contracts -€10,408
Receivables within one year +€14,126
Deferred charges and accrued income -€693
Trade debts -€15,080
Tax, wage and social debts +€21,192
Other debts +€38,749
Contributions, distributions and other -€140,000
Cash 2025 €318,656
brings cash intakes cash out
Every line side by side 38 lines
Line Code 2024 2025 Change %
Total assets 20/58 €441,119 €522,168 +€81,050 +18.4%
Fixed assets 21/28 €15,130 €10,147 -€4,983 -32.9%
Tangible fixed assets 22/27 €15,130 €10,147 -€4,983 -32.9%
Land and buildings 22 €5,446 €5,165 -€282 -5.2%
Furniture and vehicles 24 €9,684 €4,982 -€4,702 -48.5%
Current assets 29/58 €425,988 €512,021 +€86,033 +20.2%
Stocks and contracts in progress 3 €82,823 €93,231 +€10,408 +12.6%
Stocks 30/36 €82,823 €93,231 +€10,408 +12.6%
Amounts receivable within one year 40/41 €113,544 €99,418 -€14,126 -12.4%
Trade receivables 40 €112,923 €99,418 -€13,505 -12.0%
Other amounts receivable 41 €621 - -€621
Cash at bank and in hand 54/58 €229,599 €318,656 +€89,057 +38.8%
Deferred charges and accrued income 490/1 €22 €715 +€693 +3,161%
Total equity and liabilities 10/49 €441,119 €522,168 +€81,050 +18.4%
Equity 10/15 €132,009 €168,197 +€36,188 +27.4%
Contributions 10/11 €20,000 €20,000 = 0.0%
Profit (loss) carried forward 14 €112,009 €148,197 +€36,188 +32.3%
Amounts payable 17/49 €309,109 €353,972 +€44,862 +14.5%
Amounts payable within one year 42/48 €309,109 €353,972 +€44,862 +14.5%
Trade debts 44 €170,202 €155,122 -€15,080 -8.9%
Suppliers 440/4 €170,202 €155,122 -€15,080 -8.9%
Taxes, remuneration and social security 45 €38,601 €59,793 +€21,192 +54.9%
Taxes 450/3 €9,366 €32,037 +€22,671 +242%
Remuneration and social security 454/9 €29,235 €27,756 -€1,479 -5.1%
Other amounts payable 47/48 €100,307 €139,056 +€38,749 +38.6%
Remuneration, social security and pensions 62 €190,919 €200,955 +€10,036 +5.3%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €4,605 €4,983 +€379 +8.2%
Other operating charges 640/8 €4,554 €4,959 +€405 +8.9%
Gross operating margin 9900 €370,354 €451,911 +€81,557 +22.0%
Operating profit (loss) 9901 €170,277 €241,014 +€70,737 +41.5%
Financial income 75/76B €1,222 €3,338 +€2,116 +173%
Recurring financial income 75 €1,222 €3,338 +€2,116 +173%
Financial charges 65/66B €4,003 €3,265 -€738 -18.4%
Recurring financial charges 65 €4,003 €3,265 -€738 -18.4%
Profit (loss) for the period before taxes 9903 €167,496 €241,087 +€73,592 +43.9%
Income taxes 67/77 €44,379 €64,900 +€20,521 +46.2%
Profit (loss) for the period 9904 €123,117 €176,188 +€53,071 +43.1%
Profit (loss) for the period to be appropriated 9905 €123,117 €176,188 +€53,071 +43.1%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€632,063 to €851,248

Midpoint €723,390 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €168,197
Capitalised earnings €1.1m to €1.5m
Indication €632,063 to €851,248

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€168,197
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€168,197

Capitalised earnings

net result for the year (9904)
2025
€176,188
2024
€123,117
2023
€160,985
2022
€127,907
Average result
€153,430
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€1.1m / €1.3m / €1.5m

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 17 November 2026 via checked.be.